We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
VeriSign (VRSN) Q2 Earnings & Revenues Top Estimates, Up Y/Y
Read MoreHide Full Article
VeriSign (VRSN - Free Report) reported second-quarter 2022 adjusted earnings of $1.54 per share, which beat the Zacks Consensus Estimate by 1.3% and increased 17.5% year over year. Our estimate for second-quarter earnings was pegged at $1.52 per share.
Revenues jumped 6.8% year over year to $351.9 million and beat the Zacks Consensus Estimate by 0.9%. We projected revenues to be $348.8 million for the second quarter.
However, Verisign tweaked its full-year guidance due to uncertainty prevailing over global macro conditions. VeriSign expects full-year revenues between $1.415 billion and $1.43 billion compared with the earlier guided range of $1.415-$1.435 billion. VeriSign’s Domain name base growth is now expected to be between 0.5% and 1.5% as against the earlier expected range of 1.75-3.5%
Following the announcement, shares are down 2.8% in premarket trading on Jul 29.
VeriSign ended the reported quarter with 174.3 million .com and .net domain name registrations, up 2.2% year over year.
The company processed 10.1 million new domain name registrations for .com and .net compared with 11.7 million in the year-ago quarter. VeriSign saw a decrease in new units in the second quarter due to many factors, which include the pandemic-induced higher growth witnessed in the year-ago quarter along with uncertainty prevailing over global macroeconomic conditions and relative weakness in 2022 registrations from China.
The final .com and .net renewal rate for first-quarter 2022 stood at 75.9% against 76% in the year-ago quarter. Renewal rates are not fully measurable until 45 days after the end of the quarter.
Verisign will be hiking the annual registry-level wholesale fee for each new and renewal .net domain name registration to $9.92, from $9.02 with effect from Feb 1, 2023.
The company expects the renewal rate for second-quarter 2022 to be around 73.6% compared with 75.4% in the year-ago quarter.
VeriSign’s research and development (R&D) expenses increased 2.5% from the year-ago quarter’s level to $20.3 million.
Selling, general and administrative (SG&A) expenses declined 5.5% year over year to $46.1 million. As a percentage of revenues, SG&A expenses declined 170 basis points (bps) on a year-over-year basis to 13.1%.
Operating income was $236 million, up 10.8% year over year. The operating margin expanded 240 bps to 67.1%.
Balance Sheet & Cash Flow
As of Jun 30, 2022, the company’s cash and cash equivalents (including marketable securities) were $997 million compared with $1.2 billion compared with the quarter ended Mar 31, 2022.
Cash flow from operating activities was $145 million in the second quarter compared with $207 million in the previous-year quarter. Free cash flow was $139 million in the reported quarter compared with $200 million in the previous-year quarter.
In the second quarter, Verisign repurchased 2 million shares for $349 million. As of Jun 30, 2022, the company had shares worth $543 million available for future repurchases, with no expiration date.
2022 Guidance
GAAP operating margin is now expected in the 65.25-66.25% range compared with the earlier guidance of 64.5-65.5%. Ongoing focus on cost containment is likely to act as tailwind.
Capital expenditures are anticipated in the range of $30-$40 million compared with the previous expectation of $35-$45 million.
The Zacks Consensus Estimate for BMI’s 2022 earnings is pegged at $2.30 per share, up 7% in the past 60 days. Badger Meter’s earnings beat the Zacks Consensus Estimate in three of the preceding four quarters, with the average being 12.6%. Shares of BMI have lost 7.2% of their value in the past year.
The Zacks Consensus Estimate for Synopsys 2022 earnings is pegged at $8.67 per share, unchanged in the past 60 days. The long-term earnings growth rate is anticipated to be 19.6%.
Synopsys earnings beat the Zacks Consensus Estimate in the last four quarters, the average being 2.7%. Shares of SNPS have increased 25.9% in the past year.
The Zacks Consensus Estimate for Aspen’s fiscal 2022 earnings is pegged at $5.49 per share, rising 0.4% in the past 60 days. The long-term earnings growth rate is anticipated to be 16.3%.
Aspen’s earnings beat the Zacks Consensus Estimate in three of the last four quarters, the average being 4%. Shares of AZPN have grown 33.4% in the past year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
VeriSign (VRSN) Q2 Earnings & Revenues Top Estimates, Up Y/Y
VeriSign (VRSN - Free Report) reported second-quarter 2022 adjusted earnings of $1.54 per share, which beat the Zacks Consensus Estimate by 1.3% and increased 17.5% year over year. Our estimate for second-quarter earnings was pegged at $1.52 per share.
Revenues jumped 6.8% year over year to $351.9 million and beat the Zacks Consensus Estimate by 0.9%. We projected revenues to be $348.8 million for the second quarter.
However, Verisign tweaked its full-year guidance due to uncertainty prevailing over global macro conditions. VeriSign expects full-year revenues between $1.415 billion and $1.43 billion compared with the earlier guided range of $1.415-$1.435 billion. VeriSign’s Domain name base growth is now expected to be between 0.5% and 1.5% as against the earlier expected range of 1.75-3.5%
Following the announcement, shares are down 2.8% in premarket trading on Jul 29.
VeriSign, Inc. Price, Consensus and EPS Surprise
VeriSign, Inc. price-consensus-eps-surprise-chart | VeriSign, Inc. Quote
Quarter Details
VeriSign ended the reported quarter with 174.3 million .com and .net domain name registrations, up 2.2% year over year.
The company processed 10.1 million new domain name registrations for .com and .net compared with 11.7 million in the year-ago quarter. VeriSign saw a decrease in new units in the second quarter due to many factors, which include the pandemic-induced higher growth witnessed in the year-ago quarter along with uncertainty prevailing over global macroeconomic conditions and relative weakness in 2022 registrations from China.
The final .com and .net renewal rate for first-quarter 2022 stood at 75.9% against 76% in the year-ago quarter. Renewal rates are not fully measurable until 45 days after the end of the quarter.
Verisign will be hiking the annual registry-level wholesale fee for each new and renewal .net domain name registration to $9.92, from $9.02 with effect from Feb 1, 2023.
The company expects the renewal rate for second-quarter 2022 to be around 73.6% compared with 75.4% in the year-ago quarter.
VeriSign’s research and development (R&D) expenses increased 2.5% from the year-ago quarter’s level to $20.3 million.
Selling, general and administrative (SG&A) expenses declined 5.5% year over year to $46.1 million. As a percentage of revenues, SG&A expenses declined 170 basis points (bps) on a year-over-year basis to 13.1%.
Operating income was $236 million, up 10.8% year over year. The operating margin expanded 240 bps to 67.1%.
Balance Sheet & Cash Flow
As of Jun 30, 2022, the company’s cash and cash equivalents (including marketable securities) were $997 million compared with $1.2 billion compared with the quarter ended Mar 31, 2022.
Cash flow from operating activities was $145 million in the second quarter compared with $207 million in the previous-year quarter. Free cash flow was $139 million in the reported quarter compared with $200 million in the previous-year quarter.
In the second quarter, Verisign repurchased 2 million shares for $349 million. As of Jun 30, 2022, the company had shares worth $543 million available for future repurchases, with no expiration date.
2022 Guidance
GAAP operating margin is now expected in the 65.25-66.25% range compared with the earlier guidance of 64.5-65.5%. Ongoing focus on cost containment is likely to act as tailwind.
Capital expenditures are anticipated in the range of $30-$40 million compared with the previous expectation of $35-$45 million.
Zacks Rank & Stocks to Consider
VeriSign currently has a Zacks Rank #3 (Hold).
Some other top-ranked stocks from the broader technology sector worth consideration are Synopsys (SNPS - Free Report) , Aspen Technology (AZPN - Free Report) and Badger Meter (BMI - Free Report) . BMI sports a Zacks Rank #1 (Strong Buy) while Synopsys and Aspen carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for BMI’s 2022 earnings is pegged at $2.30 per share, up 7% in the past 60 days. Badger Meter’s earnings beat the Zacks Consensus Estimate in three of the preceding four quarters, with the average being 12.6%. Shares of BMI have lost 7.2% of their value in the past year.
The Zacks Consensus Estimate for Synopsys 2022 earnings is pegged at $8.67 per share, unchanged in the past 60 days. The long-term earnings growth rate is anticipated to be 19.6%.
Synopsys earnings beat the Zacks Consensus Estimate in the last four quarters, the average being 2.7%. Shares of SNPS have increased 25.9% in the past year.
The Zacks Consensus Estimate for Aspen’s fiscal 2022 earnings is pegged at $5.49 per share, rising 0.4% in the past 60 days. The long-term earnings growth rate is anticipated to be 16.3%.
Aspen’s earnings beat the Zacks Consensus Estimate in three of the last four quarters, the average being 4%. Shares of AZPN have grown 33.4% in the past year.